Monashee Investment Management’s Pliant Therapeutics PLRX Stock Holding History

Monashee Investment Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150,000	Closed	-$2.9M	–	67
2022 Q4	$2.9M	Buy	150,000 +50,000	+50%	+$1.05M	1.25%	24
2022 Q3	$2.09M	Buy	+100,000	New	+$1.91M	0.77%	21
2020 Q3	–	Sell	-36,000	Closed	-$1.17M	–	235
2020 Q2	$1.17M	Buy	+36,000	New	+$955K	0.17%	126

Other funds holding PLRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Monashee Investment Management's PLRX Position: Q1 2023 in Review

Monashee Investment Management sold out of Pliant Therapeutics (PLRX) in Q1 2023, closing a stake of 150,000 shares — an estimated $2.9M sold.

Monashee Investment Management first reported a position in PLRX in Q2 2020 and held it in 3 quarters. The position peaked at $2.9M in Q4 2022. 143 funds tracked by Wall St. Rank hold PLRX as of Q1 2023.

Monashee Investment Management reported no remaining Pliant Therapeutics position as of Q1 2023 after selling out during the quarter.
Monashee Investment Management sold 150,000 Pliant Therapeutics shares in Q1 2023, an estimated $2.9M.
Monashee Investment Management first reported a position in Pliant Therapeutics in Q2 2020 and held it in 3 quarters.
Monashee Investment Management's Pliant Therapeutics position peaked at $2.9M in Q4 2022.
143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2023.

Based on Monashee Investment Management's 13F filing for Q1 2023, filed 5 May 2023.